Danimer Scientific Stock Fundamentals
| 6CU Stock | EUR 8.50 0.00 0.00% |
DANIMER SCIENTIFIC fundamentals help investors to digest information that contributes to DANIMER SCIENTIFIC's financial success or failures. It also enables traders to predict the movement of DANIMER Stock. The fundamental analysis module provides a way to measure DANIMER SCIENTIFIC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DANIMER SCIENTIFIC stock.
DANIMER |
DANIMER SCIENTIFIC Company Total Debt Analysis
DANIMER SCIENTIFIC's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current DANIMER SCIENTIFIC Total Debt | 70.41 M |
Most of DANIMER SCIENTIFIC's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DANIMER SCIENTIFIC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, DANIMER SCIENTIFIC has a Total Debt of 70.41 M. This is 97.44% lower than that of the Healthcare sector and 78.32% lower than that of the Biotechnology industry. The total debt for all Germany stocks is 98.68% higher than that of the company.
DANIMER SCIENTIFIC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DANIMER SCIENTIFIC's current stock value. Our valuation model uses many indicators to compare DANIMER SCIENTIFIC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DANIMER SCIENTIFIC competition to find correlations between indicators driving DANIMER SCIENTIFIC's intrinsic value. More Info.DANIMER SCIENTIFIC is number one stock in ebitda category among its peers. It also is number one stock in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DANIMER SCIENTIFIC's earnings, one of the primary drivers of an investment's value.DANIMER Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DANIMER SCIENTIFIC's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DANIMER SCIENTIFIC could also be used in its relative valuation, which is a method of valuing DANIMER SCIENTIFIC by comparing valuation metrics of similar companies.DANIMER SCIENTIFIC is currently under evaluation in total debt category among its peers.
DANIMER Fundamentals
| EBITDA | (44.03 M) | |||
| Net Income | (56.63 M) | |||
| Cash And Equivalents | 82.52 M | |||
| Cash Per Share | 2.28 X | |||
| Total Debt | 70.41 M | |||
| Debt To Equity | 282.80 % | |||
| Current Ratio | 7.61 X | |||
| Book Value Per Share | 0.69 X | |||
| Cash Flow From Operations | (42.42 M) | |||
| Earnings Per Share | (1.57) X | |||
| Number Of Employees | 282 | |||
| Beta | 0.94 | |||
| Market Capitalization | 404.13 M | |||
| Z Score | 3.0 |
About DANIMER SCIENTIFIC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DANIMER SCIENTIFIC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DANIMER SCIENTIFIC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DANIMER SCIENTIFIC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. The company was incorporated in 1995 and is headquartered in Menlo Park, California. Corium International operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 213 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in DANIMER Stock
When determining whether DANIMER SCIENTIFIC is a strong investment it is important to analyze DANIMER SCIENTIFIC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DANIMER SCIENTIFIC's future performance. For an informed investment choice regarding DANIMER Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DANIMER SCIENTIFIC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in DANIMER Stock please use our How to Invest in DANIMER SCIENTIFIC guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.